This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Åhrén, C.
Right arrow Articles by Svennerholm, A.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Åhrén, C.
Right arrow Articles by Svennerholm, A.-M.

 Previous Article  |  Next Article 

Infect Immun, July 1998, p. 3311-3316, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Intestinal Immune Responses to an Inactivated Oral Enterotoxigenic Escherichia coli Vaccine and Associated Immunoglobulin A Responses in Blood

Christina Åhrén,1,2,* Marianne Jertborn,1,2 and Ann-Mari Svennerholm1

Departments of Medical Microbiology and Immunology1 and Infectious Diseases,2 Göteborg University, Göteborg, Sweden

Received 17 December 1997/Returned for modification 6 February 1998/Accepted 28 April 1998

An inactivated oral enterotoxigenic Escherichia coli (ETEC) vaccine against ETEC diarrhea was given to 25 adult Swedish volunteers. The vaccine consisted of formalin-killed E. coli bacteria expressing the most common colonization factor antigens (CFAs), i.e., CFA/I, -II, and -IV, and recombinantly produced cholera B subunit (CTB). Immunoglobulin A (IgA) antibody responses in intestinal lavage fluid to CTB and CFAs were determined and compared with corresponding responses in stool extracts and serum as well as with IgA antibody-secreting cell (ASC) responses in peripheral blood. Two doses of vaccine induced significant IgA responses to the different CFAs in lavage fluid in 61 to 87% of the vaccinees and in stool in 38 to 81% of them. The most frequent responses were seen against CFA/I. The magnitudes of the antibody responses against CTB and CFA/I in stool correlated significantly (CTB, P < 0.01; CFA/I, P < 0.05) with those in intestinal lavage. Intestinal lavage responses against CFAs were best reflected by the ASC responses, with the sensitivity of the ASC assay being 80 to 85%, followed by stool (sensitivity of 50 to 88%) and serum antibody (sensitivity of 7 to 65%) analyses. CTB-specific immune responses were seen in >90% of the vaccinees in all assays.


* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, Göteborg University, Guldhedsgatan 10, S-413 46 Göteborg, Sweden. Phone: 46-31-60 46 81. Fax: 46-31-82 69 76.


Infect Immun, July 1998, p. 3311-3316, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lapa, J. A., Sincock, S. A., Ananthakrishnan, M., Porter, C. K., Cassels, F. J., Brinkley, C., Hall, E. R., van Hamont, J., Gramling, J. D., Carpenter, C. M., Baqar, S., Tribble, D. R. (2008). Randomized Clinical Trial Assessing the Safety and Immunogenicity of Oral Microencapsulated Enterotoxigenic Escherichia coli Surface Antigen 6 with or without Heat-Labile Enterotoxin with Mutation R192G. CVI 15: 1222-1228 [Abstract] [Full Text]  
  • Qadri, F., Ahmed, T., Ahmed, F., Bhuiyan, M. S., Mostofa, M. G., Cassels, F. J., Helander, A., Svennerholm, A.-M. (2007). Mucosal and Systemic Immune Responses in Patients with Diarrhea Due to CS6-Expressing Enterotoxigenic Escherichia coli. Infect. Immun. 75: 2269-2274 [Abstract] [Full Text]  
  • Ding, M. X., Wang, Y. L., Zhu, H. L., Yuan, Z. H. (2006). Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J ANIM SCI 84: 2367-2373 [Abstract] [Full Text]  
  • Qadri, F., Ahmed, F., Ahmed, T., Svennerholm, A.-M. (2006). Homologous and Cross-Reactive Immune Responses to Enterotoxigenic Escherichia coli Colonization Factors in Bangladeshi Children.. Infect. Immun. 74: 4512-4518 [Abstract] [Full Text]  
  • McKenzie, R., Bourgeois, A. L., Engstrom, F., Hall, E., Chang, H. S., Gomes, J. G., Kyle, J. L., Cassels, F., Turner, A. K., Randall, R., Darsley, M., Lee, C., Bedford, P., Shimko, J., Sack, D. A. (2006). Comparative Safety and Immunogenicity of Two Attenuated Enterotoxigenic Escherichia coli Vaccine Strains in Healthy Adults. Infect. Immun. 74: 994-1000 [Abstract] [Full Text]  
  • Hajishengallis, G., Arce, S., Gockel, C.M., Connell, T.D., Russell, M.W. (2005). Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections. JDR 84: 1104-1116 [Abstract] [Full Text]  
  • Qadri, F., Svennerholm, A.-M., Faruque, A. S. G., Sack, R. B. (2005). Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention. Clin. Microbiol. Rev. 18: 465-483 [Abstract] [Full Text]  
  • Karlsen, T. H., Sommerfelt, H., Klomstad, S., Andersen, P. K., Strand, T. A., Ulvik, R. J., Ahren, C., Grewal, H. M. S. (2003). Intestinal and Systemic Immune Responses to an Oral Cholera Toxoid B Subunit Whole-Cell Vaccine Administered during Zinc Supplementation. Infect. Immun. 71: 3909-3913 [Abstract] [Full Text]  
  • Guerena-Burgueno, F., Hall, E. R., Taylor, D. N., Cassels, F. J., Scott, D. A., Wolf, M. K., Roberts, Z. J., Nesterova, G. V., Alving, C. R., Glenn, G. M. (2002). Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously. Infect. Immun. 70: 1874-1880 [Abstract] [Full Text]  
  • Hall, E. R., Wierzba, T. F., Ahren, C., Rao, M. R., Bassily, S., Francis, W., Girgis, F. Y., Safwat, M., Lee, Y. J., Svennerholm, A.-M., Clemens, J. D., Savarino, S. J. (2001). Induction of Systemic Antifimbria and Antitoxin Antibody Responses in Egyptian Children and Adults by an Oral, Killed Enterotoxigenic Escherichia coli plus Cholera Toxin B Subunit Vaccine. Infect. Immun. 69: 2853-2857 [Abstract] [Full Text]  
  • Altboum, Z., Barry, E. M., Losonsky, G., Galen, J. E., Levine, M. M. (2001). Attenuated Shigella flexneri 2a {Delta}guaBA Strain CVD 1204 Expressing Enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 Fimbriae as a Live Mucosal Vaccine against Shigella and ETEC Infection. Infect. Immun. 69: 3150-3158 [Abstract] [Full Text]  
  • Jertborn, M., Ahren, C., Svennerholm, A.-M. (2001). Dose-Dependent Circulating Immunoglobulin A Antibody-Secreting Cell and Serum Antibody Responses in Swedish Volunteers to an Oral Inactivated Enterotoxigenic Escherichia coli Vaccine. CVI 8: 424-428 [Abstract] [Full Text]  
  • Koprowski, H. II, Levine, M. M., Anderson, R. J., Losonsky, G., Pizza, M., Barry, E. M. (2000). Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli. Infect. Immun. 68: 4884-4892 [Abstract] [Full Text]  
  • Cohen, D., Orr, N., Haim, M., Ashkenazi, S., Robin, G., Green, M. S., Ephros, M., Sela, T., Slepon, R., Ashkenazi, I., Taylor, D. N., Svennerholm, A.-M., Eldad, A., Shemer, J. (2000). Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli-Cholera Toxin B Subunit Vaccine in Israeli Young Adults. Infect. Immun. 68: 4492-4497 [Abstract] [Full Text]  
  • Chen, H., Schifferli, D. M. (2000). Mucosal and Systemic Immune Responses to Chimeric Fimbriae Expressed by Salmonella enterica Serovar Typhimurium Vaccine Strains. Infect. Immun. 68: 3129-3139 [Abstract] [Full Text]  
  • Wenneras, C., Qadri, F., Bardhan, P. K., Sack, R. B., Svennerholm, A.-M. (1999). Intestinal Immune Responses in Patients Infected with Enterotoxigenic Escherichia coli and in Vaccinees. Infect. Immun. 67: 6234-6241 [Abstract] [Full Text]